Trevi Corp - TRVI Net earnings per share for the last four quarters

Public company logo of Trevi Therapeutics Inc (TRVI)

The prospects for Trevi Therapeutics (TRVI) are based on the development of cough and itch treatments, which require FDA approval and strategic partnerships. The YoY TTM growth in net income per share illustrates market expectations amid a liquidity shortage, where -6.70 shows the current value of the metric. Diversifying research across various pathologies mitigates regulatory risks, while success within the neuro-ecosystem relies on the uniqueness of the drugs' mechanisms of action.

Trevi Corp - TRVI Net earnings per share for the last 12 months (period 02/11/2024 - 11/18/2026)

Trevi Therapeutics Inc - analytical breakdowns and key metrics (TRVI)

Initial company analysis:Trevi Therapeutics, Inc. TRVI
Product sample of Trevi Therapeutics, Inc.

For Trevi Therapeutics (TRVI), which is developing a niche therapy for chronic cough, trailing twelve-month (TTM) EPS growth serves as an indicator of drug commercialization efficiency. The daily price action of earnings per share over twelve months allows for the real-time assessment of fundamental shifts, where an upward trend confirms the resilience of the business model, while sharp fluctuations signal overheating risks or operational expenses.

Competitor analysis for Trevi Therapeutics

Net earnings per share for the trailing year Biogen (BIIB)|neurocrine.com (NBIX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Regencell|AXSM (Axsome) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) ACADIA Pharmaceuticals Inc.|Earnings per share for the last twelve months Xenon Pharmaceuticals (XENE)|VKTX (Viking Pharma) - Earnings per share for the trailing year|Earnings per share for the last twelve months Supernus Corp SUPN|Earnings per share for the last four quarters CPRX (Catalyst Pharmaceuticals)|Denali Therapeutics - Net earnings per share (EPS TTM)|HRMY: Earnings per share for the last twelve months|Biohaven (BHVN) - Earnings per share for the last twelve months|Amylyx Pharmaceuticals Inc (AMLX) - Net earnings per share (EPS TTM)|PRAX (Praxis Corp) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Anavex Life Sciences AVXL|Net earnings per share (EPS TTM) CBLL|PRTA (prothena.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALEC (Alector Inc.)|Net earnings per share (EPS TTM) Annexon Biosciences ANNX|Omeros Corporation - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Neurogene Therapeutics NGNE|ACIU: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Voyager Therapeutics, Inc. (VYGR)|Net earnings per share for the last 12 months NMRA|Net earnings per share for the last 12 months Scilex Holding (SCLX)|Net earnings per share (EPS TTM) TVGN|Net earnings per share for the last 12 months Alpha Cognition Inc ACOG|cogrx.com - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Inhibikase Therapeutics, Inc. IKT|SAVA - Earnings per share for the last twelve months|Net earnings per share for the last four quarters Assertio ASRT|Coya Therapeutics, Inc. (COYA) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months VistaGen Therapeutics Inc|OVID (ovidrx.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ABOS|Earnings per share for the last twelve months CervoMed Corporation (CRVO)|Net earnings per share (EPS TTM) Alterity Therapeutics Ltd (ATHE)|Earnings per share for the last twelve months clene.com CLNN|PEPG (PepGen Corp) - Earnings per one share for the last 12 months|JUNS - Earnings per share for the last twelve months|RLMD (relmada.com) - Earnings per share for the last 12 months|Annovis Bio Corporation (ANVS) - Earnings per share for the last twelve months|Grace Therapeutics Inc - Earnings per share for the trailing year|AIFF (Firefly Neuro) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months KLTO|Earnings per share for the last twelve months NeuroSense Therapeutics, Ltd. (NRSN)|Reviva Pharmaceuticals - Earnings per share for the last 12 months|MetaVia Inc - Net earnings per share for the last 12 months|NRXS: Earnings per share for the last 12 months|HSDT - Earnings per share for the last twelve months|Net earnings per share for the last four quarters passagebio.com PASG|NEUP (Neuphoria Therapeutics) - Net earnings per share for the last 12 months|Net earnings per one share for the last twelve months minervaneurosciences.com (NERV)|ATHA (Athira Pharma Inc) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Addex Therapeutics, Ltd. ADXN|Net earnings per share (EPS TTM) ALZN|Net earnings per share for the last 12 months Cyclerion CYCN|Earnings per share for the last twelve months Protagenic Therapeutics Inc. PTIX|Net earnings per share for the last four quarters Pasithea (KTTA)|Cortigent Inc - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Avenue Therapeutics, Inc|BCLI (Brainstorm Cell Therapeutics, Inc.) - Net earnings per share for the last 12 months|Cara Therapeutics, Inc. (CARA) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Chromocell Therapeutics Corp|Net earnings per one share for the last twelve months eliemtx.com ELYM|Earnings per share for the last twelve months Intra-Cellular Therapies Inc. (ITCI)|Longboard Pharmaceuticals, Inc. - Earnings per share for the last 12 months|Marinus Pharmaceuticals Inc - Net earnings per share for the last 12 months|NKGen (NKGN) - Net earnings per one share for the last twelve months|NRBO - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months sagerx.com|SNPX: Net earnings per share (EPS TTM)|Trevena Inc. (TRVN) - Net earnings per share (EPS TTM)|VIGL (Vigil Neuroscience, Inc.) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months WENA (Anew Medical, Inc.)|Net earnings per share (EPS TTM) CERE